Reserve of Right Ventricular-Arterial Coupling in the Setting of Chronic Overload.


Journal

Circulation. Heart failure
ISSN: 1941-3297
Titre abrégé: Circ Heart Fail
Pays: United States
ID NLM: 101479941

Informations de publication

Date de publication:
01 2019
Historique:
entrez: 9 1 2019
pubmed: 9 1 2019
medline: 2 11 2019
Statut: ppublish

Résumé

Right ventricular (RV) maladaptation and failure determine outcome in pulmonary hypertension. The adaptation of RV function to loading (RV-pulmonary arterial coupling) is defined by a ratio of end-systolic to arterial elastances (Ees/Ea). How RV-pulmonary arterial coupling relates to pulmonary hypertension severity and onset of RV failure (defined by excessive volume increase and ejection fraction [EF] decrease) is not exactly known. We performed cardiac magnetic resonance (CMR) imaging within 24 hours of a diagnostic right heart catheterization and invasive measurement of RV pressure-volume loops in 42 patients with pulmonary hypertension. Median (interquartile range) Ees and Ea were 0.49 (0.35-0.74) and 0.74 (0.45-1.04) mm Hg/mL, respectively; Ees/Ea was 0.73 (0.47-1.07). End-diastolic elastance (Eed) was 0.14 (0.06-0.24) mm Hg/mL. RV EF was 39±13%. End-systolic volume and end-diastolic volume/body surface area (BSA) were 62 (45-101) and 104 (83-143) mL/m RV-pulmonary arterial coupling (Ees/Ea) has considerable reserve, from normal values of 1.5-2 to <0.8, and has the ability to detect pending RV failure in patients with pulmonary hypertension. Clinical Trial Registration URL: https://www.clinicaltrials.gov . Unique identifier: NCT03403868.

Sections du résumé

BACKGROUND
Right ventricular (RV) maladaptation and failure determine outcome in pulmonary hypertension. The adaptation of RV function to loading (RV-pulmonary arterial coupling) is defined by a ratio of end-systolic to arterial elastances (Ees/Ea). How RV-pulmonary arterial coupling relates to pulmonary hypertension severity and onset of RV failure (defined by excessive volume increase and ejection fraction [EF] decrease) is not exactly known.
METHODS AND RESULTS
We performed cardiac magnetic resonance (CMR) imaging within 24 hours of a diagnostic right heart catheterization and invasive measurement of RV pressure-volume loops in 42 patients with pulmonary hypertension. Median (interquartile range) Ees and Ea were 0.49 (0.35-0.74) and 0.74 (0.45-1.04) mm Hg/mL, respectively; Ees/Ea was 0.73 (0.47-1.07). End-diastolic elastance (Eed) was 0.14 (0.06-0.24) mm Hg/mL. RV EF was 39±13%. End-systolic volume and end-diastolic volume/body surface area (BSA) were 62 (45-101) and 104 (83-143) mL/m
CONCLUSIONS
RV-pulmonary arterial coupling (Ees/Ea) has considerable reserve, from normal values of 1.5-2 to <0.8, and has the ability to detect pending RV failure in patients with pulmonary hypertension. Clinical Trial Registration URL: https://www.clinicaltrials.gov . Unique identifier: NCT03403868.

Identifiants

pubmed: 30616360
doi: 10.1161/CIRCHEARTFAILURE.118.005512
doi:

Banques de données

ClinicalTrials.gov
['NCT03403868']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e005512

Commentaires et corrections

Type : CommentIn

Auteurs

Khodr Tello (K)

Department of Internal Medicine (K.T., A.D., J.A., H.A.G., W.S., N.S., J.W., H.G., M.J.R.).

Antonia Dalmer (A)

Department of Internal Medicine (K.T., A.D., J.A., H.A.G., W.S., N.S., J.W., H.G., M.J.R.).

Jens Axmann (J)

Department of Internal Medicine (K.T., A.D., J.A., H.A.G., W.S., N.S., J.W., H.G., M.J.R.).

Rebecca Vanderpool (R)

Department of Pneumology, Kerckhoff Heart, Rheuma, and Thoracic Center, Bad Nauheim, Germany (H.A.G.).

Hossein A Ghofrani (HA)

Department of Internal Medicine (K.T., A.D., J.A., H.A.G., W.S., N.S., J.W., H.G., M.J.R.).
Department of Medicine, Imperial College London, United Kingdom (H.A.G.).

Robert Naeije (R)

Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.N.).

Fritz Roller (F)

Department of Radiology (F.R.).

Werner Seeger (W)

Department of Internal Medicine (K.T., A.D., J.A., H.A.G., W.S., N.S., J.W., H.G., M.J.R.).

Natascha Sommer (N)

Department of Internal Medicine (K.T., A.D., J.A., H.A.G., W.S., N.S., J.W., H.G., M.J.R.).

Jochen Wilhelm (J)

Department of Internal Medicine (K.T., A.D., J.A., H.A.G., W.S., N.S., J.W., H.G., M.J.R.).

Henning Gall (H)

Department of Internal Medicine (K.T., A.D., J.A., H.A.G., W.S., N.S., J.W., H.G., M.J.R.).

Manuel J Richter (MJ)

Department of Internal Medicine (K.T., A.D., J.A., H.A.G., W.S., N.S., J.W., H.G., M.J.R.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH